Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating factor IX deficiency using nuclease-mediated targeted integration

Method of treating factor IX deficiency using nuclease-mediated targeted integration

US Patent 10370680 · Granted Aug 6, 2019

Estimated economic value: $12,208,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of inactivating a glucocorticoid receptor gene in an isolated cell2024
Methods and compositions for engineering immunity2023
Methods and compositions for gene inactivation2023
Method of making and using mammalian liver cells for treating hemophilia or lyso2023
Method of making and using mammalian liver cells for treating hemophilia or lyso2023
Methods and compositions for treatment of a genetic condition2022
Targeted disruption of T cell receptor genes using engineered zinc finger protei2022
Pump guard and methods of use thereof2022
Methods and compositions for targeted cleavage and recombination2022
Methods and compositions for modulating PD12022
T cell modifying compounds and uses thereof2022
Methods and compositions for genome engineering2021